Home / Cardiovascular system / Angiotensin II
ATC C01CX09 · Cardiac Therapy
Angiotensin II shortage
As of 31 Oct 2026, Angiotensin II has a reported shortage in 1 of the 5 countries we track (Belgium), covering 1 product.
Countries1/5
Products1packs or presentations
Short since3 Mar 20268 months ago
Earliest return14 Jul 2027company estimate
No return date0products
Main reasonActive ingredient shortage
Timeline
Belgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Giapreza 2.5 mg/ml inf. sol. (conc.) i.v. vial 10 x 1 ml | Paion Pharma | 3 Mar 2026 | 14 Jul 2027 | Active ingredient shortage Active Substance not available |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.